WCO, International Osteoporosis Foundation (IOF) and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) have worked in partnership for several years to develop a unique European springtime meeting programme for healthcare professionals, researchers and young scientists. With over 4,500 participants, the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases has become the largest educational event and most vibrant clinical research forum for osteoporosis, osteoarthritis and musculoskeletal diseases in Europe. The 2015 edition will commence in Milan, Italy on March 26 – 29, 2015 at the Fiera Milano Congressi (MiCo).
Topics and Speakers
- Eric Abadie
- Jonathan D. Adachi: “Monitoring of osteoporosis treatments“
- Islene Araujo de Carvalho: “Population ageing and health: the importance of policies to tackle musculoskeletal diseases“
- Nigel K. Arden: “The need for phenotyping patients in osteoarthritis“
- Francis Berenbaum: “Suggested clarification by the ESCEO working group“
- Maria Luisa Brandi
- Jaime Branco
- Olivier Bruyère: “Physical rehabilitation: which method?”, “Is it possible to phenotype patients in osteoarthritis?“
- Patricia Clark: “Epidemiology and management of post-menopausal osteoporosis in Latin America“
- Cyrus Cooper: “Guidelines diversity in glucocorticoid-induced osteoporosis“
- Maurizio Cutolo: “Inflammation and bone fragility“
- Bess Dawson‑Hughes: “Exercise, nutrition, bone and muscles“
- Elaine M. Dennison
- Jean‑Pierre Devogelaer
- Serge Ferrari: “Sequential/combined therapies in osteoporosis“
- Roger Fielding: “Osteoporosis and sarcopenia: two disorders or one?“
- Gabriel Herrero‑Beaumont
- Marc Hochberg: “Can we alter the natural history of osteoarthritis?“
- David Hunter
- John A. Kanis: “Use of FRAX worldwide: current challenges and solutions“
- Marie‑Hélèné Lafage‑Proust: “Management of osteoporosis in renal failure“
- Andrea Laslop
- Emmanuel Maheu
- Stephania Maggi
- Johanne Martel‑Pelletier
- Tim McAlindon
- Eugene McCloskey: “Evaluation of difficult cases for physicians“
- Socrates Papapoulos: “Bone anabolic therapies in osteoporosis“
- Jean‑Pierre Pelletier: “Hyaluronic acid salts in the management of osteoarthritis in Europe“
- Jean‑Yves Reginster: “Current regulatory requirements for registration of drugs to be used in osteoarthritis in Europe and need for clarification”, “Glucosamine and chondroitin salts in the management of osteoarthritis in Europe“
- Susanne Reiter‑Niesert
- Pascal Richette
- Fernando Rivadeneira
- René Rizzoli: “Genetic markers for the prediction of fragility fractures“
- Lucio C. Rovati: “How to apply for a job in a pharmaceutical company“
- Christian Roux: “How long should we treat osteoporotic patients?“
- Ego Seeman: “How to write a grant?“
- Judy Stenmark
- John C. Stevenson: “Is it time to ressurect menopause hormone therapy in osteoporosis?“
- Marjolein Visser: “Diagnosis and treatment of sarcopenia“
- José Vouillamoz
- Leith Zakraoui: “Epidemiology and management of post-menopausal osteoporosis in Middle East“
ESCEO-IOF Servier Pierre D. Delmas Prize
The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) will present in 2015 the fifth edition of the Pierre Delmas Prize, with the support of Servier.
Pierre Delmas, Professor of Medecine and Rheumatology at the University of Lyon, France, Director of the INSERM research unit « Pathophysiology of Osteoporosis », was an outstanding scientist who directed essential basic and clinical research in metabolic bone diseases, particulary in osteoporosis and osteoarthritis. He was the Founding President of the IOF.
Servier, an independant research-orientated pharmaceutical company with a long history of relationships with researchers and clinicians, particulary in the field of osteoporosis and osteoarthritis, is proud to participate, as sole sponsor, in the creation of the Pierre Delmas Prize.
The Pierre Delmas Prize will be awarded every year to an individual for outstanding and major scientific contributions to the study of bone and mineral diseases, and consists of a grant of € 40,000 and a medal.
The prize Committee will be composed of remarkable Scientists chosen within the IOF Committee of Scientific Advisors and ESCEO Scientific Advisory Board. The fifth edition of the Pierre Delmas Prize will be granted in March 2015 in Milan during the WCO IOF ESCEO Congress.
Deadline for applications is December 15, 2014.
ESCEO-IOF Herbert Fleisch Medal
This prestigious prize valued at €10,000 had been established by IOF. It is an important award which recognizes a researcher who has made outstanding and groundbreaking achievements in basic bone science. The award is named in honour of Herbert Fleisch, a renowned researcher whose groundbreaking work considerably influenced knowledge about bone and mineral metabolism.
IOF Medal of Achievement
The International Osteoporosis Foundation (IOF) Medal of Achievement honours individual researchers who have significantly advanced the field of osteoporosis through their original and outstanding scientific contributions. The award underlines important aspects of IOF’s mission – to increase understanding and awareness of osteoporosis and to promote medical innovation. The IOF Medal of Achievement, which includes CHF 1500 in prize money, is presented every year during the WCO-IOF-ESCEO congress. Candidates are nominated by members of IOF’s Committee of Scientific Advisors (CSA) and the winner selected by the Chair of the CSA with the approval of the IOF Executive Committee.
IOF President’s Awards
The International Osteoporosis Foundation (IOF) President’s Awards honour IOF members from six different regions of the world who have made a significant and unstinting contribution to the advancement of the work of the IOF, through furthering one or more of the mission statements and/or goals of the Foundation. Recipients are selected by the IOF President, with the approval of the IOF Executive Committee.
IOF Olof Johnell Science Award
The International Osteoporosis Foundation (IOF) Olof Johnell Science Award, named in honour of the late Professor Olof Johnell is awarded every year during the WCO-IOF-ESCEO congress. The Award honours an individual who has contributed to the field of osteoporosis in a scientific or policy implementation area, worldwide. The award winner also receives CHF 1500 in prize money. The candidates will be nominated by IOF members and the winner chosen by the IOF Board.
IOF Committee of National Societies Medal
The International Osteoporosis Foundation (IOF) Committee of National Societies Medal honours an individual who has made an important contribution to IOFs Committee of National Societies (CNS) through active participation in CNS activities and by expanding IOF’s message and outreach in his/her country. An IOF Committee selects the winner, with the approval of the IOF Executive Committee.
Chairmen and Scientific Committee
- Jean-Yves REGINSTER – ESCEO President
- John A. KANIS – IOF President
- Cyrus COOPER – Chair, IOF Committee Scientiﬁc Advisors (CSA)
- René RIZZOLI – Chair, ESCEO Scientiﬁc Advisory Board (SAB)
- John A. KANIS – IOF President
- Jean-Yves REGINSTER – ESCEO President
Scientific Advisory Board
Donato AGNUSDEI, Kristina AKESSON, Maurice AUDRAN, Jean-Jacques BODY, Mary BOUXSEIN, Maria-Luisa BRANDI, Olivier BRUYERE, Nansa BURLET, Etienne CAVALIER, Claus CHRISTIANSEN, Juliet COMPSTON, Cyrus COOPER, Bernard CORTET, Jean-Pierre DEVOGELAER, Andrea GASPARIK, Nicholas HARVEY, Mickaël HILIGSMANN, John A. KANIS, Jean-Marc KAUFMAN, Paul LIPS, Roman LORENC, George LYRITIS, Johanne MARTEL-PELLETIER, Eugene McCLOSKEY, Socrates PAPAPOULOS, Karel PAVELKA, Jean-Pierre PELLETIER, Jean-Yves REGINSTER, Johann RINGE, René RIZZOLI, Christian ROUX, Pavel SZULC, Thierry THOMAS